On May 9, during a live broadcast to 45,000 viewers at the inaugural Summit on Gynecologic Minimally Invasive Surgery and AI, Prof. Xiaoming Guan and Prof. Chunhua Zhang completed the world’s first vNOTES sacrocolpopexy assisted by the SHURUI® single-port robotic system.
This landmark procedure was performed entirely through the vaginal natural orifice, with no external incisions. Leveraging the robot’s snake-like instruments and 3D vision, the team achieved precise anatomical exposure and secure ligament suturing—enabling the patient to ambulate in 6 hours and be discharged in 3 days.
vNOTES is often limited by risk, precision demands, and significant technical complexity. The SHURUI® system overcomes these hurdles, offering unparalleled flexibility and accessibility—bringing gold-standard pelvic reconstructive surgery within reach for more surgeons and patients.
As SHURUI® system extends to general and thoracic surgery, it continues to redefine the boundaries of ultra-minimally invasive care in China and beyond.
Important Notes
The Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has been approved by the National Medical Products Administration (NMPA) in China for urology and gynecology laparoscopic surgeries. Surgeons who wish to learn the surgical operations of the SHURUI robot should contact Beijing Surgerii Robotics Co., Ltd. to participate in the official training program. Patients who want to participate in the registered clinical trials of the SHURUI robot should contact the official cooperative hospitals of Surgerii and consult with surgeons to determine their suitability for surgery with the SHURUI robot. Both surgeons and patients should carefully understand all information regarding the performance of surgeries by the SHURUI robot and its potential risks.
Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other
trademarks and may not be used without permission.
